Osaic Holdings’s BioLineRX BLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$59 Hold
26
﹤0.01% 7672
2025
Q4
$71 Buy
26
+25
+2,500% +$86 ﹤0.01% 7668
2025
Q3
$3 Hold
1
﹤0.01% 7882
2025
Q2
$4 Buy
+1
New +$4 ﹤0.01% 7710
2025
Q1
Sell
-30
Closed -$258 7462
2024
Q4
$258 Hold
30
﹤0.01% 7137
2024
Q3
$646 Sell
30
-5
-14% -$137 ﹤0.01% 6962
2024
Q2
$801 Buy
35
+5
+17% +$134 ﹤0.01% 6870
2024
Q1
$1.35K Sell
30
-328
-92% -$16.5K ﹤0.01% 6608
2023
Q4
$22.5K Sell
358
-247
-41% -$15.3K ﹤0.01% 5436
2023
Q3
$44K Buy
605
+107
+21% +$7.19K ﹤0.01% 5077
2023
Q2
$31.7K Sell
498
-276
-36% -$15.3K ﹤0.01% 5255
2023
Q1
$27.4K Buy
774
+744
+2,480% +$19.6K ﹤0.01% 5373
2022
Q4
$1K Sell
30
-236
-89% -$7.02K ﹤0.01% 6838
2022
Q3
$10K Sell
266
-70
-21% -$3.99K ﹤0.01% 6001
2022
Q2
$17K Sell
336
-128
-28% -$7.12K ﹤0.01% 5712
2022
Q1
$31K Buy
464
+83
+22% +$5.78K ﹤0.01% 5415
2021
Q4
$31K Buy
381
+196
+106% +$20.4K ﹤0.01% 5474
2021
Q3
$20K Buy
185
+163
+741% +$19.3K ﹤0.01% 5761
2021
Q2
$2K Hold
22
﹤0.01% 6680
2021
Q1
$2K Buy
22
+19
+633% +$2.29K ﹤0.01% 6464
2020
Q4
$0 Hold
3
﹤0.01% 6394
2020
Q3
$0 Hold
3
﹤0.01% 6203
2020
Q2
$0 Hold
3
﹤0.01% 6114
2020
Q1
$0 Buy
+3
New +$238 ﹤0.01% 6059

Other funds holding BLRX

Osaic Holdings's BLRX Position: Q1 2026 in Review

Osaic Holdings held its BioLineRX (BLRX) position steady in Q1 2026 at 26 shares worth $59. The position accounts for ﹤0.01% of the portfolio, ranked #7672.

Osaic Holdings first reported a position in BLRX in Q1 2020 and has held it in 24 quarters since. The position peaked at $44K in Q3 2023. 13 funds tracked by Wall St. Rank hold BLRX as of Q1 2026.

  • Osaic Holdings held 26 shares of BioLineRX worth $59 as of Q1 2026.
  • Osaic Holdings left its BioLineRX share count unchanged in Q1 2026.
  • BioLineRX made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7672 holding.
  • Osaic Holdings first reported a position in BioLineRX in Q1 2020 and has held it in 24 quarters since.
  • Osaic Holdings's BioLineRX position peaked at $44K in Q3 2023.
  • 13 funds tracked by Wall St. Rank held BioLineRX as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.